| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Hims & Hers Health, Inc. Cla | Aug 4, 2025 | |
| Buy | IMS HEALTH HLDGS INC | Dec 24, 2015 | |
| Buy | IMS HEALTH HLDGS INC | Dec 21, 2015 | |
| Buy | IMS HEALTH HLDGS INC | Dec 18, 2015 | |
| Buy | IMS HEALTH HLDGS INC | Dec 10, 2015 | |
| Buy | IMS HEALTH HLDGS INC | Dec 9, 2015 | |
| Buy | IMS HEALTH HLDGS INC | Dec 8, 2015 | |
| Sell | IMS HEALTH HLDGS INC | Dec 3, 2015 |
This page tracks congressional stock trading activity in Hims & Hers Health, Inc. (HIMS) in the Healthcare sector. Disclosed Capitol has indexed 8 disclosed congressional trades involving HIMS. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of September 2025 — Disclosed Capitol has tracked 8 disclosed congressional trades in Hims & Hers Health, Inc. (HIMS) — 6:1 buy-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 4, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Dec 24, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 21, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 18, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 10, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 9, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 8, 2015 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Dec 3, 2015 | Michael McCaul | R | Sale | $1,001 - $15,000 |
Across the 8 disclosed congressional trades in Hims & Hers Health, Inc. (HIMS), members of Congress have reported 6 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -31.81%.
For fiscal year 2025, Hims & Hers Health, Inc. reported revenue of $2.35B and net income of $128.4M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.36B, net income -$178.4M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.